Poolbeg Pharma Investor Relations Material
Latest events
Investor Update
Poolbeg Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Poolbeg Pharma PLC
Access all reports
Poolbeg Pharma PLC is a biotechnology company focused on the development of infectious disease treatments and immune-related therapies. The company specializes in repurposing and developing new pharmaceutical candidates using data-driven drug discovery. Poolbeg Pharma targets conditions such as severe influenza and other viral infections. The company is headquartered in London, United Kingdom, and its shares are listed on the AIM.
Key slides for Poolbeg Pharma PLC
Company Presentation
Poolbeg Pharma PLC
Company Presentation
Poolbeg Pharma PLC
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
POLB
Country
🇬🇧 United Kingdom